PF-Atlas › Drugs › ELX/TEZ/IVA

ELX/TEZ/IVA

Idiopathic Pulmonary Fibrosis

Clinical trials
7
Developer
Vertex Pharmaceuticals Incorporated

Overview

ELX/TEZ/IVA is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 7 tracked IPF clinical trials.

ELX/TEZ/IVA clinical trials

NCT05153317 (Phase 3)NCT04545515 (Phase 3)NCT05274269 (Phase 3)NCT03691779 (Phase 3)NCT04702360 (Not specified)NCT04362761 (Phase 3)NCT04105972 (Phase 3)

Explore related

All trialsResearch
Medical disclaimer. This page summarizes research about ELX/TEZ/IVA for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.